Biomea Fusion, Inc. (BMEA) vs Humacyte, Inc. (HUMA)
A side-by-side comparison of Biomea Fusion, Inc. and Humacyte, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BMEA
Biomea Fusion, Inc.
$1.29HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
HUMA
Humacyte, Inc.
$0.51HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
Total return — BMEA vs HUMA
growth of $100 · dividends reinvested · last 5yBMEA -92.4% (-40.2%/yr)HUMA -95.4% (-45.9%/yr)BMEA compounded faster over this window
BMEA HUMA
BMEA vs HUMA: by the numbers
- •BMEA is the larger company ($93M vs $85M market cap).
- •Both run net losses; BMEA's is the smaller (0.00% vs -4560.82% net margin).
Metrics side by side
Valuation
| Metric | BMEA | HUMA |
|---|---|---|
| P/S ratio | N/A | 40.15 |
| P/B ratio | 7.68 | 2.72 |
Profitability
| Metric | BMEA | HUMA |
|---|---|---|
| Gross margin | 0.00% | -736.46% |
| Operating margin | 0.00% | -5271.69% |
| Net margin | 0.00% | -4560.82% |
| ROE | -268.09% | -309.44% |
| ROIC | -220.02% | -90.27% |
Growth (annualized)
| Metric | BMEA | HUMA |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 2.41% |
| Total return CAGR (5Y) | -36.56% | -45.73% |
Frequently asked
- How have BMEA and HUMA total returns compared?
- Over the past 5 years, BMEA delivered -36.56% and HUMA delivered -45.73% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.